DARÍO ACUÑA CASTROVIEJO-rekin lankidetzan egindako argitalpenak (7)

2023

  1. A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in surgical patients with severe sepsis admitted to the intensive care unit

    Journal of Pineal Research, Vol. 74, Núm. 2

2007

  1. Attenuation of cardiac mitochondrial dysfunction by melatonin in septic mice

    FEBS Journal, Vol. 274, Núm. 8, pp. 2135-2147

  2. Cellular mechanisms involved in the melatonin inhibition of HT-29 human colon cancer cell proliferation in culture

    Journal of Pineal Research, Vol. 43, Núm. 2, pp. 195-205

2006

  1. Age-dependent lipopolysaccharide-induced iNOS expression and multiorgan failure in rats: Effects of melatonin treatment

    Experimental Gerontology, Vol. 41, Núm. 11, pp. 1165-1173

  2. Melatonin restores the mitochondrial production of ATP in septic mice

    Neuroendocrinology Letters, Vol. 27, Núm. 5, pp. 623-630

2005

  1. Selective CCK-A but not CCK-B receptor antagonists inhibit HT-29 cell proliferation: Synergism with pharmacological levels of melatonin

    Journal of Pineal Research, Vol. 39, Núm. 3, pp. 243-250

  2. The relationship between nitric oxide and ischemia-reperfusion syndrome inaortic clamping

    Angiologia, Vol. 57, Núm. 1, pp. 19-36